Paracetamol (Acetaminophen) Efficacy and Safety in the Newborn

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|14|2|178-185

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.14, Iss.2, 2013-02, pp. : 178-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Paracetamol (Acetaminophen)

By Duggan Sean T.   Scott Lesley J.  

Drugs, Vol. 69, Iss. 1, 2009-01 ,pp. : 101-113

Adis International

Access to resources Recommend Favorite

Evaluation of a 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3‐Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 95-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioequivalence and Safety of Twice‐Daily Sustained‐Release Paracetamol (Acetaminophen) Compared With 3‐ and 4‐Times‐Daily Paracetamol: A Repeat‐Dose, Crossover Pharmacokinetic Study in Healthy Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 77-86

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of prostaglandin synthesis in intact cells by paracetamol (acetaminophen)

By Graham Garry G.   Robins Sally-Anne   Bryant Katherine J.   Scott Kieran F.  

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 131-142

VSP

Access to resources Recommend Favorite

The use of paracetamol [acetaminophen] may be associated with an increased risk of multiple myeloma (MM)

By  

Reactions Weekly, Vol. 1, Iss. 1152, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite